Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D John Betteridge

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Nature Reviews. Endocrinology|December 16, 2015
The diabetogenic action of statins - mechanisms and clinical implicationsD John Betteridge, Rafael Carmena
Diabetes Research and Clinical Practice|June 15, 2005
Targeting dyslipidemia--the key to CHD risk reduction in the diabetic population?D John Betteridge, Robert S Rosenson
Lancet (London, England)|July 10, 2002
A new drug target for treatment of dyslipidaemia associated with type 2 diabetes and the metabolic syndrome?Rossitza P Naoumova, D John Betteridge
Neuroscience Letters|August 17, 2004
Plasma beta-amyloid (A beta) 40 concentration, lipid status and age in humansChristopher C T Smith, D John Betteridge
FEBS Letters|May 9, 2002
An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesisLee Stanyer, D John Betteridge, Christopher C T Smith
European Heart Journal|April 1, 2008
PROactive: time for a critical appraisalD John Betteridge, Ralph A DeFronzo, Robert J Chilton
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 4, 2002
Evaluation of methods for the extraction of nitrite and nitrate in biological fluids employing high-performance anion-exchange liquid chromatography for their determinationChristopher C T Smith, Lee Stanyer, D John Betteridge
Biochimica Et Biophysica Acta|January 24, 2004
Potentiation of beta-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivityLee Stanyer, D John Betteridge, Christopher C T Smith
Biochimica Et Biophysica Acta|November 16, 2004
Exaggerated polymerisation of beta-amyloid 40 stimulated by plasma lipoproteins results in fibrillar Abeta preparations that are ineffective in promoting ADP-induced platelet aggregationLee Stanyer, D John Betteridge, Christopher C T Smith
Neuroscience Letters|August 17, 2004
Soluble beta-amyloid (A beta) 40 causes attenuation or potentiation of noradrenaline-induced vasoconstriction in rats depending upon the concentration employedChristopher C T Smith, Lee Stanyer, D John Betteridge
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Nature Reviews. Endocrinology|December 16, 2015
The diabetogenic action of statins - mechanisms and clinical implicationsD John Betteridge, Rafael Carmena
Diabetes Research and Clinical Practice|June 15, 2005
Targeting dyslipidemia--the key to CHD risk reduction in the diabetic population?D John Betteridge, Robert S Rosenson
Lancet (London, England)|July 10, 2002
A new drug target for treatment of dyslipidaemia associated with type 2 diabetes and the metabolic syndrome?Rossitza P Naoumova, D John Betteridge
Neuroscience Letters|August 17, 2004
Plasma beta-amyloid (A beta) 40 concentration, lipid status and age in humansChristopher C T Smith, D John Betteridge
FEBS Letters|May 9, 2002
An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesisLee Stanyer, D John Betteridge, Christopher C T Smith
European Heart Journal|April 1, 2008
PROactive: time for a critical appraisalD John Betteridge, Ralph A DeFronzo, Robert J Chilton
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 4, 2002
Evaluation of methods for the extraction of nitrite and nitrate in biological fluids employing high-performance anion-exchange liquid chromatography for their determinationChristopher C T Smith, Lee Stanyer, D John Betteridge
Biochimica Et Biophysica Acta|January 24, 2004
Potentiation of beta-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivityLee Stanyer, D John Betteridge, Christopher C T Smith
Biochimica Et Biophysica Acta|November 16, 2004
Exaggerated polymerisation of beta-amyloid 40 stimulated by plasma lipoproteins results in fibrillar Abeta preparations that are ineffective in promoting ADP-induced platelet aggregationLee Stanyer, D John Betteridge, Christopher C T Smith
Neuroscience Letters|August 17, 2004
Soluble beta-amyloid (A beta) 40 causes attenuation or potentiation of noradrenaline-induced vasoconstriction in rats depending upon the concentration employedChristopher C T Smith, Lee Stanyer, D John Betteridge
Pageof 6